Human oocyte and ovarian tissue cryopreservation and its application

Area of Science:

• Reproductive Medicine and Endocrinology
• Oncology
• Cryobiology

Background:

• Cancer therapies like chemotherapy and radiotherapy frequently cause premature ovarian failure in female patients.
• There is a significant and growing need for effective fertility preservation methods for women undergoing cancer treatment.
• Current fertility preservation options can be limited, especially after intensive cancer therapies.

Purpose of the Study:

• To review recent advancements in human oocyte and ovarian tissue cryopreservation techniques.
• To assess the application of these cryopreservation technologies for preserving female fertility in cancer patients.
• To discuss the future potential and ongoing research in fertility preservation for cancer survivors and women delaying childbearing.

Main Methods:

• A comprehensive literature search was conducted using PubMed, focusing on human oocyte and ovarian tissue freezing.
• Reviewed scientific background, current technological developments, and potential future applications of cryopreservation methods.
• Synthesized findings on cryopreservation efficacy, survival rates, fertilization, and pregnancy outcomes.

Main Results:

• Significant progress has been made in the cryopreservation of both human oocytes and ovarian tissue.
• Recent laboratory improvements have enhanced oocyte survival, fertilization, and pregnancy rates following in vitro fertilization (IVF).
• Cryopreservation of ovarian tissue and oocytes shows promise for preserving reproductive potential for future use.

Conclusions:

• Oocyte cryopreservation is a key fertility preservation option for cancer patients facing infertility.
• Ovarian tissue cryopreservation is currently recommended as an experimental protocol for select patients.
• Further research is essential to improve ovarian tissue transplantation success, particularly revascularization and reducing follicular loss.